Results 111 to 120 of about 64,981 (166)
Some of the next articles are maybe not open access.

Human monoclonal antibodies

Immunology Today, 1988
Abstract Reproducible and efficient production of human monoclonal antibodies of predefined specificity has proved to be a notoriously difficult task. Many variations on basic production techniques now exist and, as Keith Thompson reviews here, the comparative ease with which they can now be made promises to open up numerous new research avenues.
openaire   +2 more sources

Monoclonal Antibodies to Human Nephrin

Hybridoma and Hybridomics, 2004
Nephrin is a 180-200-kDa transmembrane protein of the immunoglobulin superfamily. In the kidney, nephrin localizes to the slit diaphragm (SD) between interdigitating podocyte foot processes and mutations in the nephrin gene cause congenital nephrotic syndrome.
Vesa, Ruotsalainen   +4 more
openaire   +2 more sources

Generating human monoclonal antibodies

Medical Oncology and Tumor Pharmacotherapy, 1984
Present methods and systems for the generation of human monoclonal antibodies are briefly reviewed. The specificities of the available reagents are outlined. It would appear that the generation using hybridoma methods of human monoclonal antibodies to human tumor cell surface antigens is a rare event and that methods of in vitro immunostimulation may ...
A M, Neville, P A, Edwards, M J, O'Hare
openaire   +2 more sources

Human Monoclonal Antibodies to Human Cytomegalovirus

The Journal of Infectious Diseases, 1989
Human monoclonal antibodies (HMAbs) to human cytomegalovirus (HCMV) have been developed by using electric field-induced cell fusion of human B lymphocytes to the human-mouse cell line SBC-H20. By this procedure, multiple hybridomas have been produced that secrete IgG 1 HMAbs with distinct patterns of indirect immunofluorescence on HCMV-infected cells ...
S K, Foung   +6 more
openaire   +2 more sources

Humanization and Simultaneous Optimization of Monoclonal Antibody

2013
Antibody humanization is an essential technology for reducing the potential risk of immunogenicity associated with animal-derived antibodies and has been applied to a majority of the therapeutic antibodies on the market. For developing an antibody molecule as a pharmaceutical at the current biotechnology level, however, other properties also have to be
T, Kuramochi   +3 more
openaire   +3 more sources

Human Monoclonal Antibodies: The Benefits of Humanization

2018
The major reasons for developing human monoclonal antibodies were to be able to efficiently manipulate their effector functions while avoiding immunogenicity seen with rodent antibodies. Those effector functions involve interactions with the complement system and naturally occurring Fc receptors on diverse blood white cells.
openaire   +2 more sources

MONOCLONAL ANTIBODIES TO HUMAN TRANSFERRINS

British Journal of Haematology, 1988
A B, Mason, S A, Brown, R C, Penhallow
openaire   +2 more sources

Humanized Mice as a Tool to Study Sepsis—More Than Meets the Eye

International Journal of Molecular Sciences, 2021
, Laudanski Krzysztof
exaly  

The development and improvement of immunodeficient mice and humanized immune system mouse models

Frontiers in Immunology, 2022
Shuzhen Liao   +2 more
exaly  

Innovations, challenges, and minimal information for standardization of humanized mice

EMBO Molecular Medicine, 2020
Scott Kitchen   +2 more
exaly  

Home - About - Disclaimer - Privacy